メールサービス キャンペーン : 期間中に新規登録や配信希望カテゴリの変更等をされた方に、ご用意した無料レポートを提供しております。 新規登録 / 登録内容変更

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙SALE
市場調査レポート

核画像の世界市場:2017年〜2021年

Global Nuclear Imaging Market 2017-2021

発行 TechNavio (Infiniti Research Ltd.) 商品コード 325829
出版日 ページ情報 英文 117 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.44円で換算しております。
Back to Top
核画像の世界市場:2017年〜2021年 Global Nuclear Imaging Market 2017-2021
出版日: 2017年08月09日 ページ情報: 英文 117 Pages
概要

核画像の世界市場は、2017年から2021年の期間中、6.01%のCAGRで成長すると予測されています。

当レポートでは、核画像の世界市場における現状と成長の見通しを提供しており、市場の規模と今後の成長予測、市場の成長因子と課題、主要ベンダーの分析などとともにお届けします。

第1章 エグゼクティブサマリー

第2章 調査範囲

第3章 市場調査手法

第4章 イントロダクション

  • 市場の概略

第5章 市場情勢

  • 市場概要
  • ファイブフォース分析

第6章 市場区分:アプリケーション別

  • 腫瘍学
  • 心臓学
  • 神経学
  • その他

第7章 市場区分:製品別

  • スタンドアローン型PET核画像市場
  • スタンドアローン型SPECT核画像市場
  • ハイブリッド型核画像市場

第8章 市場区分:エンドユーザー別

  • 病院
  • 診断センター
  • 研究センター

第9章 地理別区分

  • 南北アメリカ
  • 欧州・中東・アフリカ
  • アジア太平洋地域

第10章 意思決定構造

第11章 市場成長促進要因と課題

第12章 市場動向

第13章ベンダー情勢

  • 競合シナリオ
  • 主なニュース

第14章 主要ベンダーの分析

  • Digirad
  • GE Healthcare
  • Mediso
  • Koninklijke Philips
  • Siemens Healthcare
  • その他の有望ベンダー

第15章 付録

  • 略語リスト

図表リスト

図表
  • Exhibit 01: Global nuclear imaging market 2016-2021 ($ millions)
  • Exhibit 02: Five forces analysis
  • Exhibit 03: Global nuclear imaging market by application 2016 (%)
  • Exhibit 04: Global nuclear imaging market by product 2016 ($ millions)
  • Exhibit 05: Global nuclear imaging market by product 2016-2021 ($ millions)
  • Exhibit 06: Global nuclear imaging market by product 2016-2021 (%)
  • Exhibit 07: Global nuclear imaging market by product 2016 and 2021 (%)
  • Exhibit 08: Global nuclear imaging market by product 2016 and 2021 ($ millions)
  • Exhibit 09: Global nuclear imaging market by product 2016 (%)
  • Exhibit 10: Nuclear imaging market by product type 2016
  • Exhibit 11: Snapshot of global PET nuclear imaging market 2016
  • Exhibit 12: Global standalone PET nuclear imaging market 2016-2021 ($ millions)
  • Exhibit 13: Snapshot of global SPECT nuclear imaging market 2016
  • Exhibit 14: Global standalone SPECT nuclear imaging market 2016-2021 ($ millions)
  • Exhibit 15: Snapshot of global hybrid nuclear imaging market 2016
  • Exhibit 16: Global hybrid nuclear imaging market 2016-2021 ($ millions)
  • Exhibit 17: Global nuclear imaging market by end-users 2016 (%)
  • Exhibit 18: Global nuclear imaging market by geography 2016
  • Exhibit 19: Global nuclear imaging market by geography 2016-2021 ($ millions)
  • Exhibit 20: Global nuclear imaging market by geography 2016-2021 (%)
  • Exhibit 21: Global nuclear imaging market by geography 2016 and 2021 ($ millions)
  • Exhibit 22: Global nuclear imaging market by geography 2016 and 2021 (%)
  • Exhibit 23: Nuclear imaging market in Americas 2016-2021 ($ millions)
  • Exhibit 24: Nuclear imaging market in EMEA 2016-2021 ($ millions)
  • Exhibit 25: Nuclear imaging market in APAC 2016-2021 ($ millions)
  • Exhibit 26: Advantages of cyclotron-based radioisotopes production
  • Exhibit 27: Competitive structure analysis of global nuclear imaging market 2016
  • Exhibit 28: Digirad: Key highlights
  • Exhibit 29: Digirad: Strength assessment
  • Exhibit 30: Digirad: Strategy assessment
  • Exhibit 31: Digirad: Opportunity assessment
  • Exhibit 32: GE Healthcare: Key highlights
  • Exhibit 33: GE Healthcare strength assessment
  • Exhibit 34: GE Healthcare strategy assessment
  • Exhibit 35: GE Healthcare opportunity assessment
  • Exhibit 36: Mediso: Key highlights
  • Exhibit 37: Mediso: Strength assessment
  • Exhibit 38: Mediso: Strategy assessment
  • Exhibit 39: Mediso: Opportunity assessment
  • Exhibit 40: Koninklijke Philips: Key highlights
  • Exhibit 41: Koninklijke Philips: Strength assessment
  • Exhibit 42: Koninklijke Philips: Strategy assessment
  • Exhibit 43: Koninklijke Philips: Opportunity assessment
  • Exhibit 44: Siemens Healthcare: Key highlights
  • Exhibit 45: Siemens Healthcare: Strength assessment
  • Exhibit 46: Siemens Healthcare: Strategy assessment
  • Exhibit 47: Siemens Healthcare: Opportunity assessment
目次
Product Code: IRTNTR14313

About Nuclear Imaging

Nuclear imaging is a branch of medical imaging which uses small amounts of radioactive tracers to diagnose, to determine severity of the disease, and treat various chronic disorders such as cancers, cardiac diseases, gastrointestinal and neurological abnormalities. PET nuclear imaging has multiple applications in clinical neurology, includes epilepsy, movement disorders, brain tumors, dementia, neuronal plasticity, and stroke. Also, it is used to diagnose oncology, cardiology (has some limited applications), and other neurodegenerative disorders. However, the majority of PET scans are used to diagnose and treat cancers. The radioactive tracers concentrate in the regions of cancer, which are detected by the PET nuclear imaging.

Technavio's analysts forecast the global nuclear imaging market to grow at a CAGR of 6.01% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global nuclear imaging market for 2017-2021. To calculate the market size, the report considers the revenue generated form the new nuclear imaging equipment sales.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Nuclear Imaging Market 2017-2021 has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • GE Healthcare,
  • Siemens Healthcare,
  • Koninklijke Philips,
  • Digirad
  • Mediso Medical Imaging Systems

Other Prominent Vendors

  • Advanced Accelerator Applications
  • Agfa-Gevaert
  • BC Technical
  • CardiArc
  • Cardinal Health
  • Carestream Health
  • CMR Naviscan
  • Cubresa
  • DDD-Diagnostic
  • Eczacibasi-Monrol Nuclear Products
  • FMI Medical Systems
  • FUJIFILM Holdings
  • MiE America
  • MILabs
  • NeuroLogica
  • Neusoft Medical Systems
  • Photo Diagnostic Systems
  • RadioMedix
  • Sofie Biosciences
  • Spectrum Dynamics Medical
  • SynchroPET
  • Toshiba Medical Systems

Market driver

  • Increasing prevalence of chronic diseases
  • For a full, detailed list, view our report

Market challenge

  • Risks and safety issues associated with nuclear imaging and radiation exposure
  • For a full, detailed list, view our report

Market trend

  • Growing focus on developing PET/MRI hybrid imaging systems
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Market outline

PART 05: Market landscape

  • Market overview
  • Five forces analysis

PART 06: Market segmentation by application

  • Oncology
  • Cardiology
  • Neurology
  • Others

PART 07: Market segmentation by product

  • Standalone PET nuclear imaging
  • Standalone SPECT nuclear imaging
  • Hybrid nuclear imaging

PART 08: Market segmentation by end-user

  • Hospitals
  • Diagnostic centers
  • Research centers

PART 09: Geographical segmentation

  • Nuclear imaging market in Americas
  • Nuclear imaging market in EMEA
  • Nuclear imaging market in APAC

PART 10: Decision framework

PART 11: Drivers and challenges

  • Market drivers
  • Market challenges

PART 12: Market trends

  • Emergence of time of flight (TOF) nuclear imaging systems
  • Growing focus on developing PET/MRI hybrid imaging systems
  • Vendors' focus on emerging economies
  • Growing focus on cyclotron-based production
  • Advances in radionanomedicine

PART 13: Vendor landscape

  • Competitive scenario
  • Key news

PART 14: Key vendor analysis

  • Digirad
  • GE Healthcare
  • Mediso
  • Koninklijke Philips
  • Siemens Healthcare
  • Other prominent vendors

PART 15: Appendix

  • List of abbreviations
Back to Top